SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-006777
Filing Date
2021-06-16
Accepted
2021-06-16 16:18:15
Documents
2
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2246
2 POWER OF ATTORNEY ex24shearman.txt EX-24 4380
  Complete submission text file 0001179110-21-006777.txt   7986
Mailing Address C/O APPLIED GENETIC TECHNOLOGIES CORP 11801 RESEARCH DRIVE, SUITE D ALACHUA FL 32615
Business Address
Shearman Mark S (Reporting) CIK: 0001643799 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37687 | Film No.: 211021725

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)